StockData
NervGen Pharma Corp. logo

NervGen Pharma Corp. (NGEN) stock

NGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$1.96+0.14 (+7.69%)

Close on Nov 17, 2026Market cap $156.11MP/E –Yield –

NervGen Pharma total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

No total debt figures for NervGen Pharma

NervGen Pharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More NervGen Pharma figures

See a number that looks wrong?